A J Gunn Selected Research

2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)

12/2019	Differential effects of slow rewarming after cerebral hypothermia on white matter recovery after global cerebral ischemia in near-term fetal sheep.
1/2011	White matter protection with insulin-like growth factor 1 and hypothermia is not additive after severe reversible cerebral ischemia in term fetal sheep.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A J Gunn Research Topics

Disease

10	Asphyxia (Suffocation) 03/2010 - 01/2000
8	Hypothermia 12/2019 - 04/2000
8	Ischemia 12/2019 - 01/2000
6	Hypoxia (Hypoxemia) 03/2010 - 03/2000
4	Brain Injuries (Brain Injury) 10/2015 - 01/2000
3	Brain Ischemia (Cerebral Ischemia) 12/2019 - 01/2011
3	Edema (Dropsy) 10/2015 - 04/2000
2	Brain Diseases (Brain Disorder) 12/2019 - 04/2006
2	Seizures (Absence Seizure) 04/2006 - 04/2000
2	Sudden Infant Death (SID) 02/2001 - 10/2000
1	Gliosis 12/2019
1	Infections 10/2015
1	Inflammation (Inflammations) 10/2015
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 10/2010
1	Chylothorax 08/2010
1	Heart Arrest (Cardiac Arrest) 04/2006
1	Hyperthermia 06/2001
1	Fever (Fevers) 06/2001
1	Demyelinating Diseases (Demyelinating Disease) 05/2001
1	Insulin Resistance 05/2001
1	Wounds and Injuries (Trauma) 03/2001
1	Hypertension (High Blood Pressure) 03/2001
1	Hypotension (Low Blood Pressure) 12/2000
1	Acidosis 12/2000
1	Cerebral Palsy (Spastic Diplegia) 01/2000

Drug/Important Bio-Agent (IBA)

9	salicylhydroxamic acid (SHAM)IBA 10/2013 - 01/2000
6	Insulin-Like Growth Factor I (IGF-1)IBA 01/2011 - 03/2000
4	Insulin (Novolin)FDA Link 08/2003 - 01/2000
3	Insulin-Like PeptidesIBA 01/2011 - 03/2000
3	Carrier Proteins (Binding Protein)IBA 01/2005 - 03/2001
2	2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA 12/2019 - 01/2011
2	ConnexinsIBA 10/2015 - 10/2013
2	Glutamic Acid (Glutamate)FDA Link 10/2015 - 01/2000
2	Caspase 3 (Caspase-3)IBA 01/2011 - 01/2007
2	Adenosine (Adenocard)FDA LinkGeneric 03/2010 - 04/2006
2	Neuroprotective AgentsIBA 01/2007 - 01/2000
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2007 - 01/2000
2	Messenger RNA (mRNA)IBA 05/2001 - 04/2001
2	AcidsIBA 03/2001 - 01/2000
1	2',3'-Cyclic Nucleotide 3'-PhosphodiesteraseIBA 12/2019
1	Myelin Basic ProteinIBA 12/2019
1	NAD (NADH)IBA 10/2015
1	Adenosine Triphosphate (ATP)IBA 10/2015
1	Connexin 43 (Connexin43)IBA 10/2013
1	Peptides (Polypeptides)IBA 10/2013
1	CaspasesIBA 01/2011
1	Biomarkers (Surrogate Marker)IBA 10/2010
1	PicibanilIBA 08/2010
1	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2010
1	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2010
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2007
1	IdazoxanIBA 10/2006
1	alpha Adrenergic ReceptorsIBA 10/2006
1	1,3-dipropyl-8-cyclopentylxanthineIBA 04/2006
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 04/2006
1	Cytotoxins (Cytolysins)IBA 04/2006
1	LipidsIBA 05/2001
1	ReninIBA 04/2001
1	Insulin-Like Growth Factor Binding ProteinsIBA 03/2001
1	Insulin-Like Growth Factor Binding Protein 1IBA 03/2001
1	Insulin-Like Growth Factor Binding Protein 2IBA 03/2001
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 03/2001
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2000
1	SmokeIBA 10/2000
1	ParvalbuminsIBA 01/2000
1	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 01/2000
1	Carboxy-LyasesIBA 01/2000
1	Neuropeptide YIBA 01/2000

Therapy/Procedure

4	Resuscitation 04/2006 - 04/2000
3	Treatment Delay 10/2015 - 03/2000
1	Rewarming 12/2019
1	Induced Hypothermia 12/2019
1	Injections 08/2010
1	Critical Care (Surgical Intensive Care) 04/2006
1	Secondary Prevention 06/2001
1	Cardiopulmonary Resuscitation (CPR) 02/2001
1	Ligation 03/2000